SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Todd who wrote (834)8/26/1998 12:23:00 PM
From: Robert Mayo  Respond to of 1060
 
All:

The WSJ ran a big article today about the growing interest in ophthalmology by the big pharmas. No mention of Insite of course. See: interactive.wsj.com@4.cgi?id=SB904083089599449500.djm&template=pj1-combo-nf.tmpl. (fee/registration)

Bob



To: Todd who wrote (834)8/29/1998 9:48:00 PM
From: jbershad  Read Replies (1) | Respond to of 1060
 
Todd, this is a very strange situation.

I don't understand Murphy or this company.

They can give the stock holders a break,
with a premium of 100% and most of us will
lose money.
Murphy in his phone presentations said this was
one of his best buys last night?

Jerry


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News